Specialized in animal brucellosis: safety and efficacy assessment of vaccines in animal models, diagnostic techniques, microbiological and molecular typing methods for the study of epidemiological relationships and control and eradication strategies. Co-author of 45 indexed research articles and 30 contributions to research conferences. Participant in 13 competitive research projects (main researcher in 2), including 2 EU funded projects. Collaborator since 2005 with the Aragon Government (Spain) in official brucellosis eradication programs and wildlife brucellosis surveillance. Trainer and consultant in international missions for the Swiss Agency for Development and Cooperation, the European Commission and Executive Agency for Health and Consumers (EAHC) and AGROTEC (EuropeAid).

PhD (2005): “Contribución a la profilaxis vacunal de la brucelosis ovina: vacunas clásicas y de Nueva generación”. Studies on Rev1 vaccine immune response, pathogenicity, infection kinetics and safety (Muñoz et al., 2008), development of Brucella rough vaccines (Barrio et al., 2009; Gonzalez et al., 2008); and subcellular vaccines with new generation adjuvants (Muñoz et al., 2006).

CITA contracts (2005- 2009): studies on brucellosis diagnostic and molecular typing (Ferrao-Beck et al., 2006; Garcia-Yoldi et al., 2007a; Garcia-Yoldi et al., 2007b; Garcia-Yoldi et al., 2006) in collaboration with the National Veterinary Research Laboratory of Porto (Portugal) and Department of Genetics of the University of Navarra (UNAV). Since 2006, studies on the epidemiological relationships between wildlife and domestic spp (Muñoz et al., 2010), with special focus on the infection caused by B. suis biovar 2 in domestic pigs and wild boar (Muñoz et al., 2012; Muñoz et al, 2019).

“Juan de la Cierva” competitive research contract (2009) at “Instituto de Agrobiotecnología de Navarra” (Idab): studies on the adjuvant effect of the EDA molecule (San Roman et al, 2012).

“DOC-INIA” competitive research contract at CITA (2010-2014): main researcher of the project “Brucelosis porcina producida por B. suis biovariedad 2: desarrollo de técnicas específicas de diagnóstico indirecto y estrategias de control y erradicación” (RTA2011-00103), yielding relevant diagnostic advances in swine brucellosis (Dieste-Pérez et al, 2014; Dieste -Pérez et al, 2015) and effective antibiotic therapy for pigs infected with B. suis bv 2 (Dieste-Pérez et al, 2015).

Permanent contract at CITA: main researcher of CITA subproject entitled "Brucellosis: diagnostic tests and DIVA vaccines against B. ovis and B. suis" (AGL2014-58795) coordinated by UNAV. Participant in the CZVeterinaria-CITA-UNAV consortium recently awarded with the "Brucellosis Vaccine Prize" to develop a safe and effective vaccine against ovine and caprine brucellosis. Responsible researcher of the Group "Bacterial Zoonoses: Brucellosis and Salmonellosis (ZooBac, A13_17R)" recognised by the Aragon Government. Main research line in progress: development of brucellosis vaccines with the objectives of i) obtaining a safe B. melitensis vaccine for sheep that improves the Rev 1 vaccine currently available by correcting its abortifacient effect and streptomycin resistance and ii) developing a vaccine against B. ovis to be used in B. melitensis-free regions.  An additional goal of my research activity is the improvement of brucellosis diagnostic techniques and development of DIVA (Differentiate Infected and Vaccinated animals) tests.